Μερκούριος Βογιατζής ΠΥΡΗΝΙΚΟΣ ΙΑΤΡΟΣ Συνεργάτης Τμημάτων Πυρηνικής Ιατρικής
και PET - CT

• Mέλος της Ελληνικής Εταιρείας Πυρηνικής Ιατρικής και Μοριακής Απεικόνισης 
• Mέλος της E.A.N.M (European Association of Nuclear Medicine)

• Ειδικευόμενος Ιατρός, Ν.Ι.Μ.Τ.Σ. Τμήμα Πυρηνικής Ιατρικής 
• Επιστημονικός Συνεργάτης τμήματος Πυρηνικής Ιατρικής Νοσοκομείου Ν.Ι.Μ.Τ.Σ. (2016 – 2017)

Κλινικό ενδιαφέρον: 

• Πυρηνική καρδιολογία 
• Πυρηνική Ογκολογία
• Θεραπείες με Ραδιονουκλίδια
• PET/CT

Ερευνητικό ενδιαφέρον:

• Cancer Theranostics
• Myocardial SPECT Perfusion Imaging

• Karfis I, Dresios C, Kotsalou I, Voyatzis M, Antoniadis D, Dimakopoulos N. Myocardial bridge: an unusual cause of asymptomatic ST-elevation during treadmill stress test causing functional ischemia. Hell J Nucl Med. 2012;15(2):147-9.
• The Utility of Rapid Parathyroid Hormone Radioimmunoassay in the Surgical Management of Hyperparathyroidism. Koutsikos I, Angelidis G, Kalogeropoulou K, Vogiatzis M, Ilia E, Evagelatou A, Velidaki A, Dimakopoulos N. 29th European Association of Nuclear Medicine Annual Congress, Barcelona, 15-19/10/2016. 
• An Overview on the Use of Pharmacologic Stress Agents in Myocardial SPECT Perfusion Imaging. Koutsikos J, Angelidis G, Vogiatzis M, Ilia E, Velidaki A, Dimakopoulos N. 2016 Society of Nuclear Medicine & Molecular Imaging Annual Meeting, San Diego, California, 11-15/06/2016.
• 99mTc-Labelled Cationic Lipophilic Complexes: An Update of their Emerging Roles in Oncology. Koutsikos J, Vogiatzis M, Ilia E, Angelidis G, Zoumboulidis A, Dimakopoulos N. 2016 Society of Nuclear Medicine & Molecular Imaging Annual Meeting, San Diego, California, 11-15/06/2016.
• Diagnostic Issues in Radioiodine Whole Body Scan: Distribution and Mechanisms of Tracer Uptake Unrelated to Thyroid Cancer. Koutsikos J, Velidaki A, Vogiatzis M, Angelidis G, Ilia E, Zoumboulidis A, Dimakopoulos N. 2016 Society of Nuclear Medicine & Molecular Imaging Annual Meeting, San Diego, California, 11-15/06/2016
• AN OVERVIEW ON THE ROLE OF SCINTIGRAPHIC IMAGING IN THE MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM. Koutsikos J [1], Angelidis G [1], Ilia E [1], Vogiatzis M [1], Velidaki A [2], Dimakopoulos N [1] J Nucl Med 2017 58:948